Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intellia Thera CS (NQ: NTLA )

43.36 -0.10 (-0.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 704,040
Open 43.40
Bid (Size) 43.28 (5)
Ask (Size) 43.76 (7)
Prev. Close 43.46
Today's Range 42.60 - 44.05
52wk Range 32.44 - 76.45
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Can This Gene-Editing Stock Deliver 10X Returns?
Buying shares of Intellia Therapeutics might be a smart move. 
Via The Motley Fool
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
Both of these stocks have declined over the past year. 
Via The Motley Fool

Performance

YTD
+25.14%
+25.14%
1 Month
-1.41%
-1.41%
3 Month
+15.87%
+15.87%
6 Month
+13.06%
+13.06%
1 Year
-16.62%
-16.62%

More News

Read More
Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You?
Via The Motley Fool
12 Analysts Have This to Say About Intellia Therapeutics
Via Benzinga
Why Intellia Therapeutics Shares Are Surging Today
Via Benzinga
Intellia Therapeutics: Q1 Earnings Insights
Via Benzinga
Intellia Therapeutics's Earnings Outlook
Via Benzinga
Where Intellia Therapeutics Stands With Analysts
Via Benzinga
Analyst Ratings for Intellia Therapeutics
Via Benzinga
The 3 Most Promising Gene Editing Stocks to Buy in 2023
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
Via InvestorPlace
3 High-Growth Biotech Stocks Poised for Success in 2023
Via InvestorPlace
2 Monster Growth Stocks That Can Double in Value, According to Wall Street
Via The Motley Fool
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
Via Benzinga
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
Via Benzinga
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
Via InvestorPlace
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Via Benzinga
3 Beaten-Down Stocks That Could Soar This Year
Via The Motley Fool
Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
2 Cathie Wood Stocks That Have Tripled Since the 2020 Market Crash
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.